Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare Biotechnology

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Comment by HaulJockeyon Nov 24, 2017 12:57pm

113 Views

Post# 27026246

RE:I’m all in..

TNATitan wrote: ..and staying long..not giving this one away..might take a while but, after doing some DD, I think the longs will be well rewarded for their patience..IMHO
Might do some bottom feeding in the next little while and double up to 1.2 Mil
Good luck to the holders!

I know what you mean! You know it's going to bust out but it's a waiting game. If you don't jump in when it's stable like this you'll be kicking yourself in the butt when "the announcment" is made and it takes off. I add a little here and there as I go and if I have a chunk of cash it's hard not to put it there knowing it'll go.

Bullboard Posts

Day trading vs. swing trading strategies for small-cap stocks